RBC Tells Clients to Buy Agios Pharma (AGIO) on Weakness
Tweet Send to a Friend
RBC Capital analsyt Kennen MacKay is telling clients buy Agios Pharma (NASDAQ: AGIO) on today's weakness/He views the 1L combo ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
